Researchers investigated the potential implications of single-nucleotide variations in gut-residing bacterial species (microbiome) on human health.
ASCO 2024: Verastem’s combo therapy for pancreatic cancer hits early trial success – Pharmaceutical Technology
Verastem will present the results at the upcoming American Society of Clinical Oncology (ASCO) Annual Meeting on 1 June 2024. Image credit: Shutterstock/CI Photos. Verastem